353 related articles for article (PubMed ID: 18276788)
1. Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.
Nagaraju K; Rawat R; Veszelovszky E; Thapliyal R; Kesari A; Sparks S; Raben N; Plotz P; Hoffman EP
Am J Pathol; 2008 Mar; 172(3):774-85. PubMed ID: 18276788
[TBL] [Abstract][Full Text] [Related]
2. Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset.
Kesari A; Fukuda M; Knoblach S; Bashir R; Nader GA; Rao D; Nagaraju K; Hoffman EP
Am J Pathol; 2008 Nov; 173(5):1476-87. PubMed ID: 18832576
[TBL] [Abstract][Full Text] [Related]
3. Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.
Rawat R; Cohen TV; Ampong B; Francia D; Henriques-Pons A; Hoffman EP; Nagaraju K
Am J Pathol; 2010 Jun; 176(6):2891-900. PubMed ID: 20413686
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.
Takahashi T; Aoki M; Suzuki N; Tateyama M; Yaginuma C; Sato H; Hayasaka M; Sugawara H; Ito M; Abe-Kondo E; Shimakura N; Ibi T; Kuru S; Wakayama T; Sobue G; Fujii N; Saito T; Matsumura T; Funakawa I; Mukai E; Kawanami T; Morita M; Yamazaki M; Hasegawa T; Shimizu J; Tsuji S; Kuzuhara S; Tanaka H; Yoshioka M; Konno H; Onodera H; Itoyama Y
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):433-40. PubMed ID: 23243261
[TBL] [Abstract][Full Text] [Related]
5. Dysferlin protein analysis in limb-girdle muscular dystrophies.
Vainzof M; Anderson LV; McNally EM; Davis DB; Faulkner G; Valle G; Moreira ES; Pavanello RC; Passos-Bueno MR; Zatz M
J Mol Neurosci; 2001 Aug; 17(1):71-80. PubMed ID: 11665864
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
[TBL] [Abstract][Full Text] [Related]
7. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
[TBL] [Abstract][Full Text] [Related]
8. Dysferlinopathy: a clinical and histopathological study of 28 patients from India.
Nalini A; Gayathri N
Neurol India; 2008; 56(3):379-85; discussion 386-7. PubMed ID: 18974568
[TBL] [Abstract][Full Text] [Related]
9. Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation.
Vafiadaki E; Reis A; Keers S; Harrison R; Anderson LV; Raffelsberger T; Ivanova S; Hoger H; Bittner RE; Bushby K; Bashir R
Neuroreport; 2001 Mar; 12(3):625-9. PubMed ID: 11234777
[TBL] [Abstract][Full Text] [Related]
10. Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice.
White Z; Sun Z; Sauge E; Cox D; Donen G; Pechkovsky D; Straub V; Francis GA; Bernatchez P
Skelet Muscle; 2022 Nov; 12(1):25. PubMed ID: 36447272
[TBL] [Abstract][Full Text] [Related]
11. New aspects on patients affected by dysferlin deficient muscular dystrophy.
Klinge L; Aboumousa A; Eagle M; Hudson J; Sarkozy A; Vita G; Charlton R; Roberts M; Straub V; Barresi R; Lochmüller H; Bushby K
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):946-53. PubMed ID: 19528035
[TBL] [Abstract][Full Text] [Related]
12. Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy.
Kawabe K; Goto K; Nishino I; Angelini C; Hayashi YK
Eur J Neurol; 2004 Oct; 11(10):657-61. PubMed ID: 15469449
[TBL] [Abstract][Full Text] [Related]
13. Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype.
Rayavarapu S; Van der Meulen JH; Gordish-Dressman H; Hoffman EP; Nagaraju K; Knoblach SM
PLoS One; 2010 Sep; 5(9):e12981. PubMed ID: 20886045
[TBL] [Abstract][Full Text] [Related]
14. [Amyloidosis in muscular dystrophy].
Carl M; Röcken C; Spuler S
Pathologe; 2009 May; 30(3):235-9. PubMed ID: 19326120
[TBL] [Abstract][Full Text] [Related]
15. Late onset in dysferlinopathy widens the clinical spectrum.
Klinge L; Dean AF; Kress W; Dixon P; Charlton R; Müller JS; Anderson LV; Straub V; Barresi R; Lochmüller H; Bushby K
Neuromuscul Disord; 2008 Apr; 18(4):288-90. PubMed ID: 18396043
[TBL] [Abstract][Full Text] [Related]
16. [Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)].
Aoki M; Takahashi T
Rinsho Shinkeigaku; 2005 Nov; 45(11):938-42. PubMed ID: 16447768
[TBL] [Abstract][Full Text] [Related]
17. Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation.
McNally EM; Ly CT; Rosenmann H; Mitrani Rosenbaum S; Jiang W; Anderson LV; Soffer D; Argov Z
Am J Med Genet; 2000 Apr; 91(4):305-12. PubMed ID: 10766988
[TBL] [Abstract][Full Text] [Related]
18. Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B.
Chase TH; Cox GA; Burzenski L; Foreman O; Shultz LD
Am J Pathol; 2009 Dec; 175(6):2299-308. PubMed ID: 19875504
[TBL] [Abstract][Full Text] [Related]
19. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.
Leriche-Guérin K; Anderson LV; Wrogemann K; Roy B; Goulet M; Tremblay JP
Neuromuscul Disord; 2002 Feb; 12(2):167-73. PubMed ID: 11738359
[TBL] [Abstract][Full Text] [Related]
20. Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.
Szymanska S; Rokicki D; Karkucinska-Wieckowska A; Szymanska-Debinska T; Ciara E; Ploski R; Grajkowska W; Pronicki M
Folia Neuropathol; 2014; 52(4):452-6. PubMed ID: 25574751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
